Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2022.07.13
Z6尊龙:2022年半年度业绩预告
2022.06.14
Z6尊龙:Z6尊龙2021年年度股东大会执法意见书
2022.06.14
Z6尊龙:2021年年度股东大会决议通告
2022.05.11
Z6尊龙:关于续聘会计师事务所的通告
2022.05.11
Z6尊龙:关于2021年年度股东大会增添暂时提案暨股东大会增补通知的通告
2022.05.11
Z6尊龙:自力董事关于第五届董事会第十九次聚会相关事项之事前认可意见
2022.05.11
Z6尊龙:自力董事关于第五届董事会第十九次聚会相关事项的自力意见
2022.05.11
Z6尊龙:第五届董事会第十九次聚会决议通告
2022.05.10
Z6尊龙:关于对深圳证券生意所2021年年报问询函回复的通告
2022.04.30
第五届董事会第十八次聚会决议通告
第一页
上一页
10
11
12
13
14
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】